ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,Y
5,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
8,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
9,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
11,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
13,2,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
14,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
15,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
15,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,5,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
15,6,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
18,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
19,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
20,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
20,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
20,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,6,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
21,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
21,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
22,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
22,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
22,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
24,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
25,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
25,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
26,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
26,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
26,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
28,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
28,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
28,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
29,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
29,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
29,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
31,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
33,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
34,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
35,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
36,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
37,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
37,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
37,3,Headache,Headaches NEC,Headaches,Nerv,N
38,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
38,2,Headache,Headaches NEC,Headaches,Nerv,N
39,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
40,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
41,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
42,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
42,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
42,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
43,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
43,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
43,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
44,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
44,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
44,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
45,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
45,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
46,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
46,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
46,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
47,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
47,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
47,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
48,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
48,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
48,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
48,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
50,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
50,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
51,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
52,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
53,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
53,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
53,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
53,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
54,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
54,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
55,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
56,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
57,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
57,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
58,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
58,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
59,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
61,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
62,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
63,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
63,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
64,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
64,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
64,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
64,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
67,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
68,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
70,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
70,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
71,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
71,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
71,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
72,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
72,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
73,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
74,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
74,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
74,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
74,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
74,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
74,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
75,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
76,1,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
76,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
77,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
77,2,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
78,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
78,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
79,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
80,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
80,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
82,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
83,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
83,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
84,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
85,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
86,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
87,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
88,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
89,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
90,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
90,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
90,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
91,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
92,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
93,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
93,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
94,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
95,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
97,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
97,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
99,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
99,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
100,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
100,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
100,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
100,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
100,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
102,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
102,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
103,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
104,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
104,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
105,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
105,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
106,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
107,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
108,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
108,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
109,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
110,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
110,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
111,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
111,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
112,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
113,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
114,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
114,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
114,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
116,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
117,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
117,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
118,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
118,2,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
118,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
119,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
119,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
120,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
121,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
122,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
122,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
122,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
122,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
124,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
124,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
124,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
124,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
125,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
125,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
126,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
127,1,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
127,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
127,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,4,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
128,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
129,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
130,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
130,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
130,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
131,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
131,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
132,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
132,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
133,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
134,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
134,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
135,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
135,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
136,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
136,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
136,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
136,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
136,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
137,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
138,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
139,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
141,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
142,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
143,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
145,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
146,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
147,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
147,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
147,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
148,2,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
148,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
149,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
150,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
151,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
152,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
152,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
152,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
153,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
153,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
154,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
155,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
156,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
157,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
157,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
157,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
157,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
158,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
158,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
158,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
159,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
160,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
161,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
161,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
161,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
161,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
161,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
161,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
161,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
161,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
162,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
163,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
163,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
163,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
163,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
163,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
163,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
163,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
164,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
164,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
164,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
164,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
164,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
165,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
165,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
165,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
166,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
166,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
166,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
166,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
166,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
167,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
167,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
167,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
167,5,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
168,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
168,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
168,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
168,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
169,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
170,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
170,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
171,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
171,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
171,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
171,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
171,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
172,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
173,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
174,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
175,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
175,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
175,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
175,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
175,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
175,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
176,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
176,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
176,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
177,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
177,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
178,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
179,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
179,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
179,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
180,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
181,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
182,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
183,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
184,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
184,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
184,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
184,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
184,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
185,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
186,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
186,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
186,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
187,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
188,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
189,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
190,1,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
190,2,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
191,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
191,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
191,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
191,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
193,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
194,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
194,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
194,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
194,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
194,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
194,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
194,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
194,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
195,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
195,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
196,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
196,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
197,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
198,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
198,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
198,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
199,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
199,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
199,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
200,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
200,2,Papillitis,Inflammations,General system disorders NEC,Genrl,N
200,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
201,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
202,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
203,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
204,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
205,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
206,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
207,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
207,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
208,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
208,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
208,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
208,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
209,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
209,2,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
209,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
209,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
210,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
210,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
210,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
211,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
212,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
212,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
212,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
212,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
212,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
212,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
212,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
212,8,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
212,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
212,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
212,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
213,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
213,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
214,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
214,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
215,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
216,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
216,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
216,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
217,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
218,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
218,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
219,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
219,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
220,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
220,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
220,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
220,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
220,5,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
220,6,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
221,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
222,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
222,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
222,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
223,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
223,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
223,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
223,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
224,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
225,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
226,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
226,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
227,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
227,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
228,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
228,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
229,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
229,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
229,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
229,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
229,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
229,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
230,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
230,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
231,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
232,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
232,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
232,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
232,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
232,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
233,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
233,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
233,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
233,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
234,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
235,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
235,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
235,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
236,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
236,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
237,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
238,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
239,1,Headache,Headaches NEC,Headaches,Nerv,N
239,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
239,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
240,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
241,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
242,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
242,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
242,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
243,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
243,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
243,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
243,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
243,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
243,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
244,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
245,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
246,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
246,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
246,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
247,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
247,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
248,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
249,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
249,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
250,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
250,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
250,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
251,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
252,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
252,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
252,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
253,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
254,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
254,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
255,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
255,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
256,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
257,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
257,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
257,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
258,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
258,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
259,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
260,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
260,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
261,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
262,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
263,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
263,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
263,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
263,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
263,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
264,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
264,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
264,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
265,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
267,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
268,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
268,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
268,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
268,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
268,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
269,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
270,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
270,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
270,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
270,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
270,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
270,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
271,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
272,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
272,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
272,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
272,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
272,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
272,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
273,1,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
274,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
274,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
274,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
274,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
274,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
274,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
275,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
276,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
276,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
277,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
277,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
277,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
278,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
278,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
278,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
279,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
279,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
280,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
281,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
281,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
283,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
283,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
284,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
285,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
286,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
287,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
287,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
288,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
288,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
288,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
288,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
288,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
289,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
290,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
290,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
291,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
291,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
291,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
292,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
292,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
292,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
293,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
294,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
295,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
295,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
296,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
297,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,1,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
298,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
299,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
299,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
299,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
299,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
299,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
300,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
300,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
301,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
301,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
302,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
302,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
303,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
304,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
304,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
304,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
305,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
305,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
305,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
305,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
306,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
307,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
308,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
308,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
308,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
308,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
308,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
309,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
310,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
310,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
310,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
311,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
311,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
311,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
312,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
313,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
314,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
315,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
315,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
315,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
315,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
316,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
318,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
319,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
319,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
319,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
320,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
320,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
320,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
321,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
321,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
321,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
322,1,Drop attacks,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
322,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
323,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
323,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
323,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
323,4,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
324,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
324,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
325,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
325,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
326,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
326,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
327,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
327,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
327,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
328,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
329,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
330,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
330,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
330,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
330,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
330,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
331,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
331,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
331,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
331,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
332,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
332,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,3,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
332,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
333,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
334,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
334,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
334,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
335,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
336,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
337,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
337,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
337,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
337,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
338,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
339,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
339,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
340,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
340,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
341,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
342,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
342,2,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
343,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
343,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
343,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
343,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
344,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
344,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
344,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
344,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
344,5,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
345,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
345,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
345,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
345,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
347,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
347,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
348,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
349,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
349,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
349,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
350,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
350,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
350,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
350,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
350,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
350,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
350,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
351,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
352,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
353,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
353,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
353,3,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
354,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
354,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
354,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
355,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
356,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
357,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
357,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
357,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
358,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
359,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
359,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
360,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
360,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
360,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
361,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
361,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
362,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
362,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
363,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
363,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
363,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
364,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
364,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
365,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
365,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
366,1,Myelodysplastic syndrome with excess blasts,Myelodysplastic syndromes,Leukaemias,Neopl,N
367,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
367,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
368,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
368,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
368,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
368,4,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
368,5,Lymph node abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
368,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
368,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
369,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
369,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
369,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
370,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
371,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
372,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
372,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
373,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
373,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
373,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
373,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
374,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
375,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
376,1,Deafness,Hearing losses,Hearing disorders,Ear,N
376,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
376,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
377,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
377,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
377,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
377,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
377,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
378,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
378,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
378,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
378,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
378,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
379,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
380,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
380,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
381,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
382,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
383,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
384,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
384,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
385,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
385,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
385,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
386,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
386,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
386,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
387,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
387,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
388,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
388,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
388,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
388,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
389,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
389,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
390,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
391,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
392,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
392,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
393,1,Hydrothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
393,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
393,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
393,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
394,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
395,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
395,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
395,3,Headache,Headaches NEC,Headaches,Nerv,N
396,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
397,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
397,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
398,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
398,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
399,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
399,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
399,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
400,1,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
400,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
400,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
400,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
400,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
401,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
402,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
402,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
402,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
402,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
402,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
403,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
403,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
404,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
404,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
405,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
406,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
407,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
407,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
407,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
408,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
408,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
409,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
409,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
409,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
409,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
410,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
410,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
410,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
410,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
410,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
410,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
412,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
412,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
413,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
413,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
413,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
413,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
413,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
414,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
414,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
416,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
416,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
416,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
416,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
416,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
416,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
416,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
416,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
417,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
417,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
417,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
417,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
417,5,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
417,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
419,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
419,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
420,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
420,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
421,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
421,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
421,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
421,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
422,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
423,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
424,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
424,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
425,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
425,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
426,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
427,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
427,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
427,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
427,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
428,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
428,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
428,3,Umbilical sepsis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
429,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
429,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
429,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
429,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
430,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
430,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
430,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
430,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
430,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
431,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
431,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
431,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
431,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
431,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
431,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
432,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
433,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
433,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
433,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
433,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
433,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
433,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
433,8,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
434,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
434,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
434,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
434,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
435,1,Deafness,Hearing losses,Hearing disorders,Ear,N
436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
437,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
438,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
439,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
440,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
440,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
440,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
440,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
440,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
441,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
442,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
442,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
442,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
443,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
443,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
443,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
443,4,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
443,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
443,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
443,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
444,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
445,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
446,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
447,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
447,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
447,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
448,1,Headache,Headaches NEC,Headaches,Nerv,N
448,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
448,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
449,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
450,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
451,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
451,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
451,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
451,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
452,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
453,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
453,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
454,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
455,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
455,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
455,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
456,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
456,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
456,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
456,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
456,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
457,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
458,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
458,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
458,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
458,4,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
459,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
459,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
459,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
459,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
460,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
461,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
461,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
461,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
462,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
463,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
464,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
465,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
465,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
466,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
467,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
468,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
468,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
468,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
469,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
470,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
470,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
470,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
471,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
471,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
472,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
472,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
472,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
473,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
474,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
474,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
474,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
474,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
474,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
475,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
475,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
475,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
475,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
476,1,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
477,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
478,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
478,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
479,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
479,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
480,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
480,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
481,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
482,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
482,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
482,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
482,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
482,5,Headache,Headaches NEC,Headaches,Nerv,N
482,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
483,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
483,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
483,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
483,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
483,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
483,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
483,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
483,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
484,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
484,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
484,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
484,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
484,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
484,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
485,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
485,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
485,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
486,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
487,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
488,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
488,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
489,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
490,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
491,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
492,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
492,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
492,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
492,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
492,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
493,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
493,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
493,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
493,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
493,5,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
493,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
494,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
494,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
494,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
494,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
495,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
495,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
495,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
496,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
497,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
497,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
497,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
498,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
499,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
500,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
500,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
501,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
502,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
503,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
503,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
503,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
503,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
503,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
503,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
504,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
504,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
505,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
506,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
506,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
506,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
506,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
506,6,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
506,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
507,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
507,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
508,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
509,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
509,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
510,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
511,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
511,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
511,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
512,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
512,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
512,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
512,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
512,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
512,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
512,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
512,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
513,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
513,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
513,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
513,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
513,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
513,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
513,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
514,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
514,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
514,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
514,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
514,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
514,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
514,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
514,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
515,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
515,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
515,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
515,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
515,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
515,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
515,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
515,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
516,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
516,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
516,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
516,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
516,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
517,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
517,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
517,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
517,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
517,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
517,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
517,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
517,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
518,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
518,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
518,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
518,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
518,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
518,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
519,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
519,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
519,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
519,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
519,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
519,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
520,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
520,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
520,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
520,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
520,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
520,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
521,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
521,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
521,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
521,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
521,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
521,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
521,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
521,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
522,1,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
523,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
524,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
525,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
526,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
526,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
526,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
526,4,Headache,Headaches NEC,Headaches,Nerv,N
526,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
526,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
526,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
527,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
528,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
528,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
528,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
528,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
528,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
528,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
529,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
530,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
530,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
531,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
532,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
533,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
533,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
533,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
533,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
534,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
535,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
536,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
536,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
537,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
537,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
538,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
538,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
539,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
539,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
540,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
541,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
542,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
542,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
543,1,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
543,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
544,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
545,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
546,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
546,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
546,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
547,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
547,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
548,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
548,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
549,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
549,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
550,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
550,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
550,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
551,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
551,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
551,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
552,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
552,3,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
552,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
552,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
553,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
554,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
555,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
556,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
557,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
558,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
559,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
559,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
560,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
561,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
561,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
561,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
561,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
561,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
561,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
562,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
563,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
564,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
565,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
565,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
566,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
566,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
566,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
566,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
566,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
566,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
566,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
566,8,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
566,9,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
566,10,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,Y
566,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
566,12,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
566,13,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
566,14,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
566,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
566,16,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
567,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
568,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
568,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
569,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
569,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
569,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
569,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
569,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
569,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
569,7,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
570,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
571,1,Aortic dissection rupture,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
572,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
572,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
572,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
573,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
574,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
574,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
574,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
574,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
575,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
575,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
576,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
576,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
577,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
577,2,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
577,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
577,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
577,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
577,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
577,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
578,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
579,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
580,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
580,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
580,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
581,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
581,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
581,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
581,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
581,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
582,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
582,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
583,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
583,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
583,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
583,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
583,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
584,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
585,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
586,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
587,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
587,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
587,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
588,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
589,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
589,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
589,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
590,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
591,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
591,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
591,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
591,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
592,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
592,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
592,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
592,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
593,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
593,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
593,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
594,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
595,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
596,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
596,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
596,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
596,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
597,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
597,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
598,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
598,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
599,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
600,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
600,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
600,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
600,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
600,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
601,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
601,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
601,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
601,4,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
602,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
602,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
602,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
602,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
602,5,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
602,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
602,7,Grandiosity,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
602,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
602,9,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
603,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
604,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
605,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
605,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
605,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
605,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
605,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
606,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
606,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
607,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
607,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
607,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
608,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
608,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
609,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
610,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
611,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
611,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
611,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
612,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
612,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
612,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
612,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
613,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
613,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
614,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
614,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
615,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
615,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
615,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
616,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
616,2,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
616,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
616,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
617,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
617,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
618,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
618,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
619,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
619,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
619,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
620,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
621,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
622,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
622,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
623,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
623,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
623,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
624,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
625,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
626,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
626,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
627,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
628,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
629,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
629,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
629,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
630,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
631,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
631,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
631,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
632,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
632,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
633,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
634,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
634,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
634,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
634,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
634,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
634,6,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
634,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
634,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,11,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
634,12,Headache,Headaches NEC,Headaches,Nerv,N
634,13,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
634,14,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
634,15,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
634,16,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
634,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,18,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
634,19,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
634,20,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
634,21,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
634,22,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
634,23,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,24,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
634,25,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
635,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
635,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
635,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
635,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
635,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
635,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
636,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
636,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
636,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
636,4,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
636,5,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
636,6,Histiocytic necrotising lymphadenitis,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
636,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
636,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
636,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
636,10,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
636,11,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
636,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
636,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
636,14,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
636,15,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
637,1,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
638,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
639,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
639,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
639,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
639,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
640,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
640,2,Post procedural urine leak,Urinary tract procedural complications,Procedural related injuries and complications NEC,Inj&P,N
641,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
641,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
641,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
641,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
642,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
642,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
643,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
644,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
644,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
644,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
644,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
645,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
646,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
647,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
647,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
648,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
648,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
648,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
648,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
649,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
649,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
650,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
650,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
650,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
651,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
651,2,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
651,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
651,4,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
651,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
651,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
651,7,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
652,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
653,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
653,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
654,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
654,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
654,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
654,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
654,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
655,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
655,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
655,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
655,4,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
655,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
656,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
657,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
657,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
657,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
657,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
657,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
659,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
659,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
659,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
660,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
660,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
660,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
660,4,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
661,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
661,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
662,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
663,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
664,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
664,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
664,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
665,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
665,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
665,3,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
666,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
666,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
666,3,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
667,1,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
668,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
669,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
670,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
671,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
671,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
672,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
672,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
673,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
673,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
674,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
674,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
674,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
674,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
674,5,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
674,6,Hepatic vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
674,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
674,8,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
674,9,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
674,10,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
674,11,Ischaemic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
674,12,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
674,13,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
674,14,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
674,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
674,16,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
674,17,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
674,18,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
675,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
675,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
675,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
675,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
675,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
676,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
677,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
678,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
678,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
679,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
679,2,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
680,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
681,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
682,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
683,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
683,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
683,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
683,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
683,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
684,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
685,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
686,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
687,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
688,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
689,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
689,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
689,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
689,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
689,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
689,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
689,7,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
690,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
691,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
691,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
691,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
691,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
691,5,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
691,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
691,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
691,8,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
691,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
692,1,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
692,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
693,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
693,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
693,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
693,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
693,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
693,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
694,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
694,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
694,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
694,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
695,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
695,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
695,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
695,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
696,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
696,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
696,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
696,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
697,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
698,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
698,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
699,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
699,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
699,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
700,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
701,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
701,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
701,3,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
701,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
703,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
704,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
704,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
704,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
705,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
705,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
705,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
705,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
706,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
706,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
706,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
706,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
707,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
707,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
708,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
708,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
708,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
708,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
708,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
709,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
709,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
709,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
709,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
709,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
710,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
711,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
712,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
713,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
714,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
715,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
716,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
716,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
716,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
716,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
716,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
716,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
716,7,Salivary gland cancer stage IV,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
716,8,Small cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
716,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
717,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
717,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
718,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
719,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
719,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
719,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
720,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
721,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
721,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
721,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
721,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
721,6,Gamma-glutamyltransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
721,7,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
721,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
721,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
721,10,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
721,11,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
721,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
721,13,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
721,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
721,15,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
721,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
721,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
721,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
722,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
723,1,Mucosal infection,Infections NEC,Infections - pathogen unspecified,Infec,N
723,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
724,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
724,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
724,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
724,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
724,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
725,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
725,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
725,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
726,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
726,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
726,3,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
726,4,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
726,5,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
726,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
726,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
726,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
726,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
726,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
726,11,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
726,12,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
726,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
726,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
726,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
727,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
728,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
729,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
730,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
730,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
731,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
731,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
731,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
731,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
731,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
731,7,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
731,8,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
731,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
732,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
733,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
734,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
735,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
736,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
736,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
736,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
736,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
736,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
736,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
737,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
738,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
738,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,1,Corneal epithelium defect,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
739,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
739,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
739,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
740,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
740,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
740,3,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
740,4,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
740,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
740,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
740,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
740,8,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
740,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
740,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
741,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
741,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
742,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,Y
742,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
743,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
743,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
743,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
743,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
743,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
743,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
743,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
743,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
743,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
743,10,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
743,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
744,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
745,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
746,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
747,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
747,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
748,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
749,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
749,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
750,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
750,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
751,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
751,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
752,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
752,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
752,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
752,4,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
752,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
752,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
752,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
752,8,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
752,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
752,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
752,11,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
752,12,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
752,13,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
752,14,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
752,15,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
752,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
752,17,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
752,18,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
752,19,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
752,20,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
752,21,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
752,22,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
752,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
752,24,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
752,25,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
752,26,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
752,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
752,28,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
752,29,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
752,30,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
753,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
753,2,Systemic candida,Candida infections,Fungal infectious disorders,Infec,Y
754,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
754,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
755,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
755,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
756,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
757,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
758,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
759,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
760,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
761,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
761,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
762,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
763,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
763,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
763,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
763,5,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
764,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
765,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
765,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
765,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
765,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
765,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
765,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
766,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
766,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
767,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
767,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
768,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
769,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
770,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
770,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
770,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
771,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
772,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
772,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
773,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,N
773,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
773,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
774,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
774,2,Hepatic vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
774,3,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
774,4,Ischaemic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
774,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
774,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
774,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
774,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
775,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
775,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
775,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
775,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
776,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
776,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
776,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
776,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
777,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
777,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
777,3,Histiocytic necrotising lymphadenitis,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
777,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
777,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
777,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
778,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
779,1,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
779,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
779,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
779,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
780,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
780,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
780,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
781,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
781,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
781,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
782,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
782,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
782,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
782,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
782,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
783,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
783,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
784,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
784,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
784,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
784,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
785,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
785,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
786,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
786,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
787,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
788,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
788,2,Metastases to kidney,Metastases to specified sites,Metastases,Neopl,N
788,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
788,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
788,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
788,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
788,7,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
789,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
789,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
789,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
789,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
790,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
790,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
790,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
790,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
790,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
791,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
791,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
791,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
791,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
792,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
792,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
793,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
793,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
794,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
794,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
794,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
794,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
794,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
795,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
795,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
795,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
795,4,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
795,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
796,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
796,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
797,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
797,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
798,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
799,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
799,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
799,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
800,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
801,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
802,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
803,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
803,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
804,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
805,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
805,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
805,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
805,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
805,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
806,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
806,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
806,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
806,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
807,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
808,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
809,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
810,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
810,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
810,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
810,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
811,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
811,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
811,3,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
811,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
811,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
811,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
811,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
812,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
813,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
813,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
813,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
813,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
813,5,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
814,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
814,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
814,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
814,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
815,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
815,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
815,3,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
815,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
815,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
815,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
815,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
815,8,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
815,9,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
815,10,Lymphadenectomy,Lymphoid tissue therapeutic procedures,Haematological and lymphoid tissue therapeutic procedures,Surg,N
815,11,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
815,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
815,13,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
815,14,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
815,15,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
815,16,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
815,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
815,18,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
816,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
816,2,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
816,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
816,4,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
817,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
817,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
817,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
817,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
817,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
818,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
818,2,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
818,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
818,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
818,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
818,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
818,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
818,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
818,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
819,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
820,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
821,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
822,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
822,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
822,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
822,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
822,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
822,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
822,7,Gamma-glutamyltransferase,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
822,8,Haemoglobin,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
822,9,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
822,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
822,11,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
822,12,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
822,13,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
822,14,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
822,15,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
822,16,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
822,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
822,18,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
822,19,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
822,20,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
822,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
822,22,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
822,23,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
822,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
823,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
823,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
823,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
823,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
823,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
824,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
825,1,Abdominal operation,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
825,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
825,3,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
825,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
825,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
825,6,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
825,7,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
825,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
825,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
825,10,Gastrointestinal scarring,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
825,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
825,12,Intestinal strangulation,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
825,13,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
825,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
825,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
825,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
826,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
826,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
826,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
826,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
826,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
826,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
826,7,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
826,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
826,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,10,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
826,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
826,12,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
826,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
826,14,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
826,15,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
826,16,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
826,17,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,18,Plantar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
826,19,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
826,20,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
826,21,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
826,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
827,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
827,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
828,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
828,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
828,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
828,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
828,5,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
828,6,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
828,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
828,8,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
828,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
828,10,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
828,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
828,12,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
828,13,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
828,14,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
828,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
828,16,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
828,17,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
828,18,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
828,19,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
828,20,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
828,21,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
828,22,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
829,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
829,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
829,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
829,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
829,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
829,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
829,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
829,8,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
830,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
830,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
831,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
831,2,Laryngeal cancer stage III,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
831,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
831,4,Lung carcinoma cell type unspecified stage III,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
831,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
831,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
831,7,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
832,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
832,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
833,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
834,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
834,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
835,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
835,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
835,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
835,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
835,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
835,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
835,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
835,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
835,9,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
835,10,Paraneoplastic rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
835,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
835,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
835,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
836,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
836,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
836,3,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
837,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
838,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
839,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
839,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
840,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
840,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
841,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
842,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
843,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
844,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
844,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
845,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
846,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
847,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
847,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
847,3,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
847,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
848,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
848,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
848,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
848,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
849,1,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
849,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
850,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
850,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
851,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
851,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
851,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
852,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
852,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
853,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
854,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
854,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
855,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
856,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
857,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
858,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
858,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
858,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
858,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
859,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
859,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
859,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
859,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
860,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
860,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
860,3,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
861,1,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
862,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
863,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
864,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
864,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
864,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
864,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
864,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
865,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
866,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
866,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
866,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
866,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
867,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
867,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
868,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
868,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
869,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
869,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
869,3,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
870,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
871,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
871,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
872,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
872,2,Endocarditis candida,Candida infections,Fungal infectious disorders,Infec,N
872,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
872,4,Shunt malfunction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
873,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
874,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
874,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
875,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
875,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
875,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
876,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
876,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
877,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
877,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
878,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
878,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
879,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
880,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
880,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
880,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
881,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
881,3,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
881,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
881,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
881,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
882,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
883,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
884,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
884,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
885,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
886,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
886,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
886,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
886,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
886,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
886,6,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
886,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
886,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
886,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
886,10,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
886,11,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
886,12,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
886,13,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
886,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
886,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
886,16,Terminal agitation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
886,17,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
886,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
887,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
888,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
889,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
890,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
891,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
892,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
893,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
894,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
894,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
894,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
894,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
894,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
895,1,Administration related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
895,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
895,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
895,4,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
895,5,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
896,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
897,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
897,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
898,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
899,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
899,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
899,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
900,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
901,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
902,1,Glioneuronal tumour,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
902,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
903,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
903,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
903,4,Necrotising scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
903,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
903,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
904,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
904,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
904,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
904,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
904,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
905,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
905,2,Neuroblastoma,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
905,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
907,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
907,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
908,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
908,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
908,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
909,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
910,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
910,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
910,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
911,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
911,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
912,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
912,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
912,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
912,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
912,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
912,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
913,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
914,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
915,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
915,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
916,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
917,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
918,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
918,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
919,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
919,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
920,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
921,1,5-hydroxyindolacetic acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
921,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
921,3,Blood gastrin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
921,4,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
921,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
921,6,Borderline ovarian tumour,Female reproductive neoplasms unspecified malignancy,Reproductive neoplasms female malignant and unspecified,Neopl,N
921,7,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
921,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
921,9,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
921,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
921,11,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
921,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
921,13,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
921,14,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
921,15,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
921,16,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
921,17,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
921,18,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
921,19,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
921,20,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
921,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
921,22,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
921,23,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
921,24,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
921,25,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
921,26,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
922,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
923,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
923,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
923,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
924,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
925,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
926,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
927,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
927,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
927,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
928,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
928,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
928,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
929,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
930,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
931,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
931,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
931,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
931,4,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
932,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
932,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
933,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
934,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
934,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
935,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
936,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
936,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
936,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
937,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
937,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
937,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
937,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
938,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
939,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
939,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
939,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
939,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
940,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
940,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
940,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
940,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
941,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
941,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
941,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
942,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
942,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
942,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
942,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
942,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
942,6,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
942,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
942,8,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
943,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
944,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
944,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
944,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
945,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
945,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
945,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
946,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
946,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
946,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
946,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
946,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
947,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
947,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
947,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
947,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
947,5,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
947,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
947,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
948,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
948,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
949,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
949,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
950,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
951,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
952,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
953,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
954,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
954,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
955,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
955,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
956,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
956,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
956,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
956,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
956,5,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
956,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
957,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
957,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
957,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
957,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
958,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
959,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
959,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
959,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
960,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
960,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
960,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
960,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
961,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
961,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
962,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
962,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
963,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
964,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
964,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
964,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
965,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
966,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
966,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
966,3,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
967,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
968,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
968,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
968,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
968,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
968,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
969,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
969,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
969,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
970,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
970,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
970,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
971,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
971,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
972,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
972,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
972,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
972,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
973,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
973,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
974,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
974,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
974,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
975,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
976,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
977,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
977,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
978,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
978,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
978,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
978,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
978,5,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
978,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
979,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
980,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
980,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
980,3,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
980,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
981,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
982,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
982,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
982,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
982,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
982,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
982,6,Renal tubular injury,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
982,7,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
983,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
983,2,Ovarian germ cell teratoma stage I,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
984,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
984,2,Ovarian germ cell teratoma stage I,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
985,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
985,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
986,1,Ovarian germ cell teratoma,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
987,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
987,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
987,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
987,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
988,1,Ovarian germ cell teratoma,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
989,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
990,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
990,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
991,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
991,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
991,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
991,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
992,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
992,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
992,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
992,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
993,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
993,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
993,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
993,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
994,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
994,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
994,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
994,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
995,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
995,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
996,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
996,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
996,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
996,4,Nephritis,Nephritis NEC,Nephropathies,Renal,N
997,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
998,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
998,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
998,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
998,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
999,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1000,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1000,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1000,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1000,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1001,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1001,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1001,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1002,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1002,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1003,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1003,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1003,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1004,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1004,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1004,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1005,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1006,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1006,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1007,1,Metastases to the mediastinum,Metastases to specified sites,Metastases,Neopl,N
1007,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1007,3,Thymus enlargement,Thymus disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1008,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
1008,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1009,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1009,2,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
1009,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1009,4,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1009,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1010,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
1010,2,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1010,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1011,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1012,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1012,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1013,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1013,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1013,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1014,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1015,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1015,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1015,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1015,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1016,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1016,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1016,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1017,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1018,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1018,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1019,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1019,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1019,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1019,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1019,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1020,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1020,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1020,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1020,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1020,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1020,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1021,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1021,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1021,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1021,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1022,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1022,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1023,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1023,2,Serous cystadenocarcinoma ovary,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1024,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1024,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1025,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1025,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1025,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1025,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1025,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1025,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1025,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1026,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1027,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1028,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1028,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1028,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1029,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1029,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1029,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1029,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1029,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1029,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1030,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1030,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1030,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1030,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1030,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1030,6,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1030,7,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
1030,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1030,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1030,10,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1030,11,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1030,12,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1031,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1031,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1031,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1031,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1031,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1032,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1033,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1034,1,Bile duct stenosis,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1034,2,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1034,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1034,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1034,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1034,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1034,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1034,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
1035,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1035,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1035,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1035,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1036,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1037,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1037,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1037,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1037,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1038,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1039,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1040,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1040,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1040,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1040,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1041,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1041,2,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1041,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1041,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1041,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1042,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1042,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1042,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1043,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1044,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1044,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1045,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1045,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1046,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1046,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1046,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1046,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1046,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1047,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1048,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1048,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1048,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1048,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1049,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1049,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1050,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1050,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1050,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1051,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1051,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1051,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1051,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1051,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1051,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1052,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1053,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1053,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1053,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1054,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1054,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1054,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1054,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1054,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1054,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1055,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1056,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1056,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1056,3,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
1056,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1057,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1057,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1057,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1057,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1057,5,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
1057,6,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1057,7,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1058,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1059,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1059,2,May-Thurner syndrome,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1059,3,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1059,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1059,5,Pelvic organ injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1059,6,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1060,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1061,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1061,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1061,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1062,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1062,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1062,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1063,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1063,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1064,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1064,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1064,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1064,4,Pelvic discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1064,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1064,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1065,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1065,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1065,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1065,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1065,5,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1065,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1065,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1065,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1065,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1066,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1067,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,2,Ovarian cancer stage IV,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1068,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1068,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1068,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1069,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1069,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1069,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1070,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1070,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1071,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1071,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1071,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1071,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1072,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1072,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1073,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1073,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1073,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1073,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1074,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1074,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1075,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1075,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1076,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1078,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1079,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1079,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1079,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1080,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1081,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1082,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1082,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1082,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1082,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1083,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1083,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1083,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1084,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1084,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1084,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1084,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1084,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1085,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1085,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1085,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1085,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1085,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1085,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1085,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1085,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1085,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1085,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1085,11,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1086,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1086,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1086,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1086,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1086,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1086,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1086,7,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1087,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1088,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1088,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1089,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1089,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1089,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1089,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1089,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1090,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1090,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1090,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1090,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1091,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1091,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1091,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1092,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1093,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1093,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1094,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1095,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1095,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1095,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1096,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1096,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1097,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1098,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1098,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1099,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1100,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1101,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1102,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1102,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1102,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1102,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1102,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1103,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1104,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1104,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1104,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1104,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1105,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1105,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1105,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1105,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1105,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1105,6,Headache,Headaches NEC,Headaches,Nerv,N
1105,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1105,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1105,9,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1105,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1105,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1106,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1106,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1107,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1108,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1108,2,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1109,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1109,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1109,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1109,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1110,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1110,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1111,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1111,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1112,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1113,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1113,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1113,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1114,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1114,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1114,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1114,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1114,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1114,7,Headache,Headaches NEC,Headaches,Nerv,N
1114,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1114,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1115,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1115,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1115,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1115,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1115,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1115,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1116,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1116,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1117,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1117,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1117,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1117,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1117,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1117,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1117,7,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1118,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1119,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1119,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1119,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1120,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1120,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1120,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1120,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1120,5,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1120,6,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1120,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1120,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1120,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1120,10,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1120,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1120,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1120,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1120,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1120,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1120,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1120,17,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1120,18,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1120,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1120,20,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1120,21,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1120,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1121,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1121,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1121,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1121,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1121,5,Scar pain,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1122,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1122,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1123,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1123,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1123,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1123,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1123,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1123,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1123,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1123,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1124,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1124,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1125,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1125,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1126,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1127,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1127,2,Lung adenocarcinoma stage IV,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1127,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1127,4,Metastases to uterus,Metastases to specified sites,Metastases,Neopl,N
1128,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1128,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1129,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1129,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1130,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1130,2,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
1130,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1130,4,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1131,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1131,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1131,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1132,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1133,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1133,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1134,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1135,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1135,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1136,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1136,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1136,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1136,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1137,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1138,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1139,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1139,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1139,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1140,1,Headache,Headaches NEC,Headaches,Nerv,N
1140,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1140,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1140,4,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1141,1,Headache,Headaches NEC,Headaches,Nerv,N
1141,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1141,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1141,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1142,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1142,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1142,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1143,1,Headache,Headaches NEC,Headaches,Nerv,N
1143,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1143,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1143,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1143,5,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1144,1,Headache,Headaches NEC,Headaches,Nerv,N
1144,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1144,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1144,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1145,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1146,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1146,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1146,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1147,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1147,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1148,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1148,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1148,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1149,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1149,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1149,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1149,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1149,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1149,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1149,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1149,9,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1149,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1149,12,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1149,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1149,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1149,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1149,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1150,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1150,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1150,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1151,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1151,2,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1151,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1151,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1151,5,Headache,Headaches NEC,Headaches,Nerv,N
1151,6,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1151,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1152,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1153,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1153,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1153,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1153,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1154,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1154,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1155,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1155,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1155,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1155,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1155,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1155,7,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1155,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1155,9,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1156,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1156,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1156,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1157,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1157,2,Migraine,Migraine headaches,Headaches,Nerv,N
1157,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1157,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1158,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1158,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1158,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1158,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1158,5,Headache,Headaches NEC,Headaches,Nerv,N
1158,6,Headache,Headaches NEC,Headaches,Nerv,N
1158,7,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1158,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1158,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1158,10,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1158,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1158,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1159,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1159,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1159,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1159,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1160,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1160,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1160,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1161,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1162,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1162,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1162,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1162,4,Headache,Headaches NEC,Headaches,Nerv,N
1162,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1162,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1162,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1163,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1163,2,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1163,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1163,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1163,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1163,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1163,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1163,8,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1164,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1164,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1164,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1164,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1165,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1165,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1165,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1165,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1166,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1166,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1166,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1167,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1167,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1167,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1167,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1168,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1168,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1168,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1168,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1168,5,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1168,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1168,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1168,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1168,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1168,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1168,11,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1169,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1169,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1169,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1169,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1169,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1169,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1169,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1169,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1169,9,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1169,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1169,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1170,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1170,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1170,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1170,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1170,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1170,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1170,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1170,8,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1170,9,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1170,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1170,11,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
1170,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1171,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1172,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1172,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1172,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1172,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1172,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1172,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1172,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1172,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1172,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1172,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1173,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1173,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1174,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1174,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1175,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1175,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1175,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1176,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1176,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1176,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1176,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1176,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1177,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1178,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1178,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1178,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1178,4,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
1178,5,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1179,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1180,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1181,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1182,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1182,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1182,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1182,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1183,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1183,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1184,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1184,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1184,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1184,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1185,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1185,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1185,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1185,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1185,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1186,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1186,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1186,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1186,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1187,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1188,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1188,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1188,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1189,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1190,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1191,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1192,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1192,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1193,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1193,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1193,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1193,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1193,5,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1193,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1193,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1193,8,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1194,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1194,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1194,3,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1194,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1195,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1195,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1195,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1195,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1195,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1195,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1195,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1196,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1196,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1197,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1197,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1197,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1198,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1199,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1199,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1200,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1201,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1201,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1202,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1202,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1202,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1203,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1203,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1203,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1204,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1204,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1204,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1205,1,Hyponatraemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1206,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1206,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1206,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1206,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1206,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1206,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1206,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1206,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1206,9,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1206,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1207,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1207,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1208,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1208,2,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1209,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1209,2,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1210,1,Headache,Headaches NEC,Headaches,Nerv,N
1210,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1210,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1210,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1211,1,Headache,Headaches NEC,Headaches,Nerv,N
1211,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1211,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1212,1,Headache,Headaches NEC,Headaches,Nerv,N
1212,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1212,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1213,1,Headache,Headaches NEC,Headaches,Nerv,N
1213,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1213,3,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1214,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1215,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1215,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1216,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1217,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1217,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1217,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1217,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1218,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1218,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1219,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1220,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1220,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1220,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1220,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1220,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1220,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1220,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1220,8,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1220,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1220,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1220,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1220,12,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1220,13,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1220,14,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1220,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1220,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1220,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1220,18,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1220,19,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1220,20,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1220,21,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1220,22,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1220,23,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1220,24,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1220,25,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1220,26,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1220,27,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1220,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1220,29,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1220,30,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1220,31,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1221,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1221,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1221,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1221,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1221,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1221,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1221,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1221,8,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1222,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1222,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1223,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1224,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1224,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1225,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1225,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1225,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1226,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1227,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1227,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1228,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1229,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1229,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1230,1,Acquired gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1230,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1230,3,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1231,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1231,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1232,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1232,2,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1232,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1233,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1233,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1233,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1234,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1234,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1234,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1235,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1235,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1236,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1236,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1236,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1236,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1236,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1236,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1236,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1237,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1237,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1237,3,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1237,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1237,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1237,6,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1238,1,Blood creatinine,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1238,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1238,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1239,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1239,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1239,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1240,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
1240,2,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
1241,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1241,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1243,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1243,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1243,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1243,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1244,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1244,2,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1245,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1246,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1246,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1247,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1248,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1249,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1250,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1250,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1251,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1251,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1252,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1253,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1254,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1255,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1256,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1256,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1257,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1258,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1259,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1259,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1259,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1259,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1259,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1259,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1259,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1259,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1259,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1260,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1261,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1262,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1262,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1262,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1263,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1263,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1263,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1264,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1264,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1264,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1264,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1264,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1264,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1264,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1264,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1264,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1265,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1266,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1266,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1267,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1267,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1268,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1268,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1268,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1269,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1270,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1270,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1271,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1272,1,Bundle branch block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1272,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1272,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1272,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1272,5,Postural orthostatic tachycardia syndrome,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1272,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1272,7,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1272,8,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1272,9,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1272,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1273,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1273,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1273,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1273,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1273,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1273,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1273,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1273,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1273,9,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1274,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1274,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1275,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1276,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1277,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1278,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1279,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1279,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1279,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1279,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1279,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1279,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1279,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1280,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1280,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1280,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1280,4,Headache,Headaches NEC,Headaches,Nerv,N
1280,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1280,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1280,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1281,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1282,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1282,2,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1282,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1283,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1283,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1283,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1283,4,Clostridium bacteraemia,Clostridia infections,Bacterial infectious disorders,Infec,N
1283,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1283,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1283,7,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1283,8,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1283,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1283,10,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1283,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1283,12,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1283,13,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1283,14,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1283,15,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1283,16,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1283,17,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1284,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1284,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1284,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1285,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1286,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1286,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1286,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1286,4,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1286,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1286,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1287,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1288,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1288,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1289,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1290,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1290,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1291,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1292,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1292,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
1292,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1292,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1292,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1293,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1293,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
1294,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1295,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1296,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1296,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1296,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1296,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1296,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1296,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1297,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1297,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1297,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1297,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1298,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1299,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1300,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1301,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1302,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1302,2,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1302,3,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1303,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1303,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1304,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1305,1,Diastolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1306,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1306,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1306,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1306,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1306,5,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1306,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1306,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1306,8,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1306,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1306,10,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1307,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1307,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1307,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1308,1,Amnestic disorder,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1309,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1309,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1309,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1310,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1310,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1310,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1311,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1312,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1312,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1312,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1312,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1312,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1312,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1313,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1314,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1314,2,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1314,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1314,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1314,5,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1314,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1314,7,Lung squamous cell carcinoma stage III,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1314,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1314,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1314,10,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1314,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1315,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1315,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1316,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1317,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1317,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1318,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
1318,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1318,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1318,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1318,5,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1318,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1319,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
1319,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1319,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1319,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1320,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1321,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1321,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1322,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1323,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1324,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1324,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1324,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1324,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1324,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1325,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1326,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1326,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1327,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1327,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1327,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1327,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1328,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1328,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1328,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1329,1,Anterior segment ischaemia,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
1329,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1329,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1329,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1330,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1330,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1331,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1332,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1332,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1333,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1333,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1333,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1333,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1334,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1334,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1334,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1334,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1335,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1335,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1335,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1335,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1335,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1335,6,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1335,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1336,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1337,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1337,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
1338,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1338,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1338,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1339,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1340,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1341,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1341,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1341,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1342,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1342,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1342,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1342,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1342,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1342,6,Cryptitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1342,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1342,8,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1342,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1342,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1342,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1342,12,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1342,13,Gastrointestinal angiodysplasia,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
1342,14,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1342,15,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1342,16,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1342,17,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1342,18,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1342,19,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1342,20,Metastases to pancreas,Metastases to specified sites,Metastases,Neopl,N
1342,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1342,22,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1342,23,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1342,24,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1342,25,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
1342,26,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1342,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1343,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1343,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1344,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1344,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1344,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1344,4,Metastases to pleura,Metastases to specified sites,Metastases,Neopl,N
1345,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
1345,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1346,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1346,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1347,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1347,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1347,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1348,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1349,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1349,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1349,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1349,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1350,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1350,2,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1351,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1351,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1351,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1352,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1352,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1352,3,Headache,Headaches NEC,Headaches,Nerv,N
1352,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1353,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1354,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1354,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1354,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1355,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1355,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1355,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1355,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1355,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1356,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1357,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1358,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1359,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1359,3,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1360,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1360,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1360,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1360,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1360,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1361,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1361,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
1362,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1362,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1362,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1363,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1363,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1364,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1364,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1365,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1366,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1366,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1366,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1367,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1368,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1369,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1369,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1369,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1369,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1369,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1369,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1369,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1370,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1370,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1370,3,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,N
1370,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1370,5,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1370,6,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1370,7,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1370,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1370,9,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1370,10,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1370,11,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1370,12,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1370,13,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1371,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1371,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1371,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1371,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1371,5,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1371,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1372,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1372,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1372,3,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,N
1372,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1372,5,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1372,6,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1372,7,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1372,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1372,9,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1372,10,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1372,11,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1372,12,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1372,13,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1373,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1373,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1374,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1374,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1374,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1374,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1374,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1375,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1375,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1376,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1376,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1377,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1378,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1378,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1378,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1378,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1379,1,Cervix carcinoma recurrent,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1379,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1379,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1379,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1380,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1380,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1380,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1380,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1380,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1380,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1380,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1380,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1380,9,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1380,10,Fungating wound,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1380,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1380,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1380,13,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1380,14,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1380,15,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1380,16,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1380,17,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1380,18,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1380,19,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1380,20,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1381,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1381,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1381,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1381,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1381,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1382,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1382,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1382,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1383,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1383,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1383,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1383,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1384,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1385,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1386,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1387,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1387,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1387,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1387,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1388,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1389,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1389,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1389,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1389,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1390,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1391,1,Urinary bladder toxicity,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1392,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1392,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1392,3,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1392,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1393,1,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1393,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1393,3,Periventricular leukomalacia,Encephalopathies NEC,Encephalopathies,Nerv,Y
1394,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1394,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1394,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1394,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1395,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1395,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1396,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1397,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1397,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1398,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1398,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1399,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1399,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1400,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1401,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1401,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1401,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1402,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1402,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1402,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1402,4,Metastases to kidney,Metastases to specified sites,Metastases,Neopl,N
1402,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1403,1,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1403,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1404,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1405,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1405,2,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
1406,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1406,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1407,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1407,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1407,3,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1408,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1409,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1410,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1411,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1411,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1412,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1412,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1412,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1412,4,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1413,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1413,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1413,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1414,1,Arteriosclerotic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1414,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1414,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1414,4,Optic disc haemorrhage,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1414,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1414,6,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1414,7,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1415,1,Arteriosclerotic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1415,2,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
1415,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1415,4,Optic disc haemorrhage,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1415,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1415,6,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1415,7,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1415,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1416,1,Arteriosclerotic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1416,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1416,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1416,4,Optic disc haemorrhage,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1416,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1416,6,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1416,7,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1417,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1417,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1417,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1417,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1418,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1419,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1419,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1420,1,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1421,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1421,2,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
1421,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1421,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1421,5,Stoma creation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1422,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1422,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1422,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1423,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1423,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1423,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1423,4,Gastrointestinal stoma output abnormal,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
1423,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1423,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1423,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1423,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1423,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1424,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1425,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
1426,1,Arteriosclerotic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1426,2,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
1426,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1426,4,Optic disc haemorrhage,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1426,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1426,6,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1426,7,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1427,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1427,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1427,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1427,4,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1427,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1428,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1428,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1428,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1428,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1428,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1429,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1430,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1430,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1430,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1430,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1431,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
1432,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1432,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1432,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1432,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1432,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1434,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1435,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1437,1,Dairy intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
1438,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1438,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1438,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1439,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1439,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1440,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1440,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1440,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1440,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1440,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1440,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1441,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1442,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1442,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1442,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1443,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1444,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1444,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1445,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1446,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1446,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1447,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1448,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1448,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1448,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1449,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1449,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1449,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1449,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1449,5,Catheter site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1449,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1449,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1449,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1449,9,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1449,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,12,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1449,13,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1449,14,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1449,15,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1449,16,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,17,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,18,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1449,19,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,20,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1449,21,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1449,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1449,23,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,24,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1449,25,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1449,26,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1449,27,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1449,28,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1450,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1451,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1452,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1452,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1452,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1453,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1453,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1453,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1453,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1453,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1453,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1454,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1455,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1455,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1456,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1457,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1458,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1458,2,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1458,3,Resorption bone increased,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1459,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1459,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1459,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1459,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1459,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1459,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1460,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1460,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1461,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1462,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1463,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1463,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1463,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1464,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1464,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1464,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1464,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1464,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1464,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1465,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1465,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1466,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1467,2,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1467,3,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1467,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1468,1,Cervix carcinoma recurrent,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1468,2,Female genital tract fistula,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1469,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1469,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1469,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1470,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1470,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1470,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1470,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1470,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1470,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1470,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1470,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1470,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1470,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1470,11,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1470,12,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1470,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1470,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1470,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1470,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1470,17,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1470,18,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1470,19,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1470,20,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1470,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1470,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1470,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1470,24,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1470,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1470,26,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1470,27,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1470,28,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1470,29,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1470,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1470,31,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1471,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1472,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1472,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1472,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1472,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1472,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1472,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1472,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1472,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1472,9,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1472,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1473,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1475,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1476,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1477,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1477,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1478,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1478,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1478,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1478,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1478,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1478,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1478,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1479,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1480,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1480,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1480,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1481,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1482,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1482,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1482,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1482,4,Device ineffective,Device issues NEC,Device issues,Prod,N
1482,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1482,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1482,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1482,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1482,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1482,10,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1482,11,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1482,12,Tracheal mass,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1483,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1484,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1485,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1486,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1487,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1487,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1487,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1487,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1487,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1487,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1487,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1487,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1487,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1487,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1487,11,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1487,12,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1487,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1487,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1487,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1487,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1487,17,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1487,18,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1487,19,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1487,20,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1487,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1487,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1487,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1487,24,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1487,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1487,26,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1487,27,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1487,28,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1487,29,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1487,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1487,31,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1488,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1488,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1488,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1489,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1489,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1489,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1489,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1490,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1490,2,Activated partial thromboplastin time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1490,3,Blood albumin abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1490,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1490,5,Blood potassium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1490,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1490,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1490,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1490,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1490,10,Haematocrit abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1490,11,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1490,12,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1490,13,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1490,14,Prothrombin time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1490,15,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1490,16,Red blood cell count abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1491,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1491,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1491,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1492,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1493,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1493,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1493,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1493,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1493,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1493,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1493,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1493,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1494,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1494,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1495,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1495,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1495,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1495,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1495,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1495,6,Death,Death and sudden death,Fatal outcomes,Genrl,N
1495,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1495,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1495,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1495,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1495,11,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1495,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1495,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1495,14,Headache,Headaches NEC,Headaches,Nerv,N
1495,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1495,16,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1495,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1495,18,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1495,19,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1495,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1495,21,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1495,22,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1495,23,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1495,24,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1495,25,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1495,26,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
1495,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1496,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1496,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1497,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1497,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1498,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1498,2,Basal ganglia infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1498,3,Basophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1498,4,Bladder wall calcification,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1498,5,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1498,6,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1498,7,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1498,8,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1498,9,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1498,10,Headache,Headaches NEC,Headaches,Nerv,N
1498,11,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1498,12,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1498,13,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1498,14,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1498,15,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1498,16,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1498,17,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
1498,18,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1498,19,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1498,20,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1498,21,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1498,22,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1498,23,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1498,24,Tri-iodothyronine free decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1498,25,Venous angioma of brain,Venous disorders congenital,Cardiac and vascular disorders congenital,Cong,N
1498,26,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1498,27,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,1,Anorectal malformation,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1499,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1499,3,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1499,4,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1499,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1499,6,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1499,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1499,8,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1499,12,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,13,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,14,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1499,16,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1499,17,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,18,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,19,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1499,20,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,21,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1499,22,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1499,23,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1500,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1500,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1501,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1501,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1501,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1502,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1502,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1502,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1503,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1503,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1503,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1504,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1504,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1504,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1505,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1505,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1506,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1506,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1506,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1507,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1507,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1508,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1508,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1509,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1510,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1511,1,Secondary cerebellar degeneration,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1512,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1512,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1513,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1513,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1513,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1513,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1513,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1513,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1513,7,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1513,8,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1515,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1515,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1516,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1517,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1517,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1517,3,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
1518,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1519,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1519,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1519,3,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1520,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1521,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1521,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1522,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1522,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1522,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1522,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1523,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1523,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1523,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1523,4,Tumour excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1524,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1524,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1525,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1526,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1526,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1527,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1528,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1528,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1529,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1529,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1530,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1530,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1531,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1532,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1532,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1533,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1533,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1534,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1535,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1535,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1536,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1537,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1537,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1537,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1537,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1537,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1537,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1537,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1537,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1537,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1538,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1539,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1540,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1541,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1542,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1542,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1542,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1542,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1543,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1543,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1543,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1543,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1543,5,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1543,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1544,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1544,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1544,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1544,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1544,5,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1544,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1544,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1545,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1546,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1547,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1548,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1548,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1548,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1549,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1549,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1549,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1550,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1550,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1551,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1551,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1551,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1552,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1553,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1554,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1554,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1554,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1554,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1554,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1554,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1554,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1554,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1555,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1556,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1556,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1556,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1556,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1556,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1557,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1557,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1558,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1559,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1560,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1561,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1561,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1561,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1561,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1562,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1562,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1562,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1562,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1563,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1564,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1565,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1565,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1565,3,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1565,4,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1565,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1566,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1567,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1568,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1569,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1569,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1569,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1570,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1570,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1570,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1571,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1571,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1571,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
1571,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1572,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1572,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1573,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1574,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1574,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1575,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1575,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1576,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1576,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1576,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1577,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1577,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1577,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1577,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1577,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1578,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1579,1,Adenocarcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1579,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1579,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1580,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1580,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1580,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1580,4,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1580,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1580,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1580,7,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1581,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1581,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1582,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1583,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1584,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1584,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1586,1,Adenocarcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1586,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1586,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1587,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1587,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1588,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1589,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1589,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1590,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1590,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1590,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1590,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1590,5,Headache,Headaches NEC,Headaches,Nerv,N
1590,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1590,7,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1590,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1590,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1590,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1590,11,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1590,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1590,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1590,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1591,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1592,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1593,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1593,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1594,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1594,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1594,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1595,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1595,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1596,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1596,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1596,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1596,5,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1596,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1597,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1597,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1598,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1598,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1598,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1599,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1599,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1600,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1600,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1601,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1601,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1601,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1602,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1602,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1603,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1603,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1603,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1603,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1604,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1605,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1606,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1607,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1607,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1608,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1608,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1609,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1610,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1611,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1612,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1612,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1613,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1613,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1614,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1614,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1614,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1614,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1615,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1616,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1616,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1616,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1617,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1617,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
